Citations 12

Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients With Renal Cell Carcinoma

JAMA Oncology | May 29, 2020 | Volume: 6 | Issue: 10 | Pages: 1606

10.1001/jamaoncol.2020.2169 | PMID 32469396

Axitinib: from preclinical development to future clinical perspectives in renal cell carcinoma

Expert Opinion on Drug Discovery | June 3, 2015 | Volume: 10 | Issue: 8 | Pages: 925-935

10.1517/17460441.2015.1045411 | PMID 26039031